These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30746998)

  • 21. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li AM; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006340. PubMed ID: 18425949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
    Yin SS; Liu H; Gao X
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
    Gelb AF; Flynn Taylor C; Shinar CM; Gutierrez C; Zamel N
    Chest; 2006 Jun; 129(6):1492-9. PubMed ID: 16778266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.
    Couillard S; Shrimanker R; Chaudhuri R; Mansur AH; McGarvey LP; Heaney LG; Fowler SJ; Bradding P; Pavord ID; Hinks TSC
    Am J Respir Crit Care Med; 2021 Sep; 204(6):731-734. PubMed ID: 34129808
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on Exhaled Nitric Oxide in Clinical Practice.
    Mummadi SR; Hahn PY
    Chest; 2016 May; 149(5):1340-4. PubMed ID: 26836891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management.
    Arnold RJ; Massanari M; Lee TA; Brooks E
    Manag Care; 2018 Jul; 27(7):34-41. PubMed ID: 29989900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide in children with asthma.
    Park YA; Park HB; Kim YH; Sul IS; Yoon SH; Kim HR; Kim KW; Kim KE; Sohn MH
    J Asthma; 2017 Aug; 54(6):644-651. PubMed ID: 28055271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pathophysiological approach for FeNO: A biomarker for asthma.
    Ricciardolo FL; Sorbello V; Ciprandi G
    Allergol Immunopathol (Madr); 2015; 43(6):609-16. PubMed ID: 25796309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in asthma biomarker research.
    Leung TF; Ko FW; Wong GW
    Ther Adv Respir Dis; 2013 Oct; 7(5):297-308. PubMed ID: 23907809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MODERN APPROACHES TO FRACTIONAL EXHALED NITRIC OXIDE AS A USEFUL BIOMARKER FOR ALLERGIC ASTHMA PHENOTYPING AND MANAGEMENT.
    Mgaloblishvili N; Gotua M
    Georgian Med News; 2017 Dec; (273):51-55. PubMed ID: 29328030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age on relationship between exhaled nitric oxide and airway hyperresponsiveness in asthmatic children.
    Motomura C; Odajima H; Tezuka J; Murakami Y; Moriyasu Y; Kando N; Taba N; Hayashi D; Okada K; Nishima S
    Chest; 2009 Aug; 136(2):519-525. PubMed ID: 19395581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FeNO in Asthma.
    Loewenthal L; Menzies-Gow A
    Semin Respir Crit Care Med; 2022 Oct; 43(5):635-645. PubMed ID: 35253144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between exhaled nitric oxide and exposure to low-level environmental tobacco smoke in children with asthma on inhaled corticosteroids.
    de la Riva-Velasco E; Krishnan S; Dozor AJ
    J Asthma; 2012 Sep; 49(7):673-8. PubMed ID: 22799435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of using exhaled NO in asthma diagnosis and management.
    Ludviksdottir D; Diamant Z; Alving K; Bjermer L; Malinovschi A
    Clin Respir J; 2012 Oct; 6(4):193-207. PubMed ID: 22898078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of high fractional exhaled nitric oxide among US youth with asthma.
    Nguyen DT; Kit BK; Brody D; Akinbami LJ
    Pediatr Pulmonol; 2017 Jun; 52(6):737-745. PubMed ID: 28524604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The long-term variability of FeNO in pregnant asthmatic women with controlled asthma].
    Dor-Wojnarowska A; Nittner-Marszalska M; Liebhart J; Marszalska H; Pawłowicz R; Gillert M; Kazimierczak A; -Filarska MK; Panaszek B
    Pneumonol Alergol Pol; 2013; 81(2):114-20. PubMed ID: 23420427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scottish consensus statement on the role of FeNO in adult asthma.
    Kuo CR; Spears M; Haughney J; Smith A; Miller J; Bradshaw T; Murray L; Williamson P; Lipworth B
    Respir Med; 2019 Aug; 155():54-57. PubMed ID: 31299469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fraction of exhaled nitric oxide as biomarker of asthmatic airway inflammation].
    Lange P; Ulrik CS; Hilberg O
    Ugeskr Laeger; 2019 May; 181(19):. PubMed ID: 31120016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional exhaled nitric oxide in clinical trials: an overview.
    Häussermann S; Kappeler D; Schmidt A; Siekmeier R
    Adv Exp Med Biol; 2013; 788():237-45. PubMed ID: 23835984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.